455 defendants charged in massive $6.5 billion health care fraud takedown

The Justice Department on Tuesday, June 23, charged 455 defendants, including 90 physicians and other licensed medical professionals, in what officials called one of the largest coordinated health care fraud enforcement actions on record. The cases span 56 federal districts and 45 states and territories, involving more than $6.5 billion in alleged false claims, along with conduct prosecutors say caused serious patient harm and, in at least one case, a patient's death.

The 2026 National Health Care Fraud Takedown drew participation from 50 state Medicaid Fraud Control Units, the most in the department's history, and produced the largest number of Medicaid fraud defendants and the largest Medicaid loss the department has ever charged: 295 defendants and more than $518 million in false claims. Investigators seized over $182 million in cash, luxury vehicles, jewelry and other assets.

The Centers for Medicare & Medicaid Services (CMS) separately suspended 1,079 individuals and entities from billing federal programs and revoked the billing privileges of 1,403 others.

"This year's National Health Care Fraud Takedown represents the greatest whole-of-government effort to combat health care fraud in our Nation's history," Acting Attorney General Todd Blanche said in a statement.

Assistant Attorney General Colin M. McDonald, who leads the National Fraud Enforcement Division the department created in April, added: "If you put profit over patients, you should expect to be put in prison."

A data-driven era of enforcement

One notable trend held true across the cases announced Tuesday — the government's growing reliance on data analytics to flag suspicious billing before, and not just after, the money goes out the door.

The Health Care Fraud Unit's Data Fusion Center, staffed by analysts from the unit, the Department of Health and Human Services Office of Inspector General (HHS-OIG) and the Federal Bureau of Investigations (FBI), contributed to many of the charges. Officials also announced the first prosecution from the unit's Financial Intelligence Review Team, a $67 million case in which an Illinois man allegedly billed Medicaid for more than 500 hours of counseling and therapy a day, well beyond what his staff could have delivered around the clock. Prosecutors said the investigation opened within five days of the financial review, and the defendant was arrested at an airport less than seven months later as he allegedly tried to leave the country.

CMS Administrator Mehmet Oz, M.D., MBA, tied the cases to a broader change in posture. "CMS is done playing catch-up," he said. "We're deploying advanced data analytics to expose fraud networks, freeze suspicious payments, and shut down bad actors before they can do damage to the programs that millions of Americans depend on."

The analytics shift is also what compliance specialists say physicians should watch most closely.

Shannon Sumner, CPA, CHC, who leads the regulatory compliance service line at the consulting and accounting firm PYA, told Medical Economics that the enforcement climate has changed in kind, not just degree.

"The enforcement environment in 2026 is really more data driven and pattern focused than ever before," she said. "Investigations are increasingly triggered by analytics, so practices get flagged because their data doesn't look like their peers."

The targets have changed, too, Sumner said. Where the focus once fell on large systems, insurers and Medicare Advantage plans, "they're going after individual physicians," in part because analytics make them easier to spot. "These are easy targets," she said, "with the use of the data analytic tools." She noted that CMS has invested heavily in those capabilities, at one point running what she described as a "chili cook-off" contest to recruit vendors building better fraud-detection software.

Pat Naples, an attorney at ArentFox Schiff whose practice focuses on health care litigation and government investigations, said the toolset is older than the headlines suggest. Claims data mining was written into federal regulations as a potential basis for a credible allegation of fraud back in 2011, he told Medical Economics, and the current activity is "really the continuation of a trend that's been in place for a number of years, and we've seen it across administrations."

In practice, Naples said, the government is usually looking for "large outliers in the data set," not a single odd claim.

That distinction matters, because a credible allegation of fraud is the threshold CMS must clear to suspend a practice's payments, and the determination rests largely with the agency. A physician whose payments are withheld "can submit a written rebuttal statement," Naples said, but whether the agency considers or rejects it is discretionary, and formal review runs through the administrative appeals process before any case reaches a court.

Billions tied to wound care

Some of the largest dollar figures came from a category many physicians give little thought to: amniotic wound allografts, the skin-substitute products used to treat wounds. Prosecutors charged 11 defendants, including a company executive and eight medical professionals, in connection with billions of dollars in allograft claims.

In Arizona, the vice president of sales for an allograft company was charged in what prosecutors describe as a nationwide kickback scheme.

From December 2021 through June 2024, Medicare was billed more than $4 billion for the company's products, drawing more than $2 billion in payments. According to the charges, the company bought allografts from tissue banks, relabeled them and resold them at a 2,000% markup, charging as much as $1,450 per square centimeter, then paid out roughly 40% of that in kickbacks.

The executive allegedly took home more than $24 million, which he spent on multimillion-dollar homes, a $135,000 Maserati and other luxuries. The charges follow prison sentences of 15.5 and 14 years handed down last year in the same scheme.

Two of the cases centered on nurse practitioners. In the Southern District of Texas, prosecutors charged a nurse practitioner in a $906 million scheme, alleging she applied medically unnecessary allografts and billed Medicare more than $1 million per patient on average. The government seized more than $30 million from bank accounts, a $594,000 Ferrari, an $865,000 custom Bulgari necklace and money tied to a $4.6 million beach resort under construction in the Philippines. In Florida, three defendants were charged in a $118 million allograft scheme in which a nurse practitioner allegedly spent the proceeds on a luxury box at an NFL stadium and more than $400,000 in fine art.

The allograft cases also show how quickly Medicare's exposure can grow. The Health Care Fraud Unit's analysts detected the spike in allograft payments, and CMS separately realigned its reimbursement, cutting payment to $127 per square centimeter as of Jan. 1, 2026. Had CMS not acted, the agency said, the resulting Part B premium increase from allograft spending alone would have cost every Medicare beneficiary an extra $11 a month.

Schemes that put patients at risk

Several cases involved alleged harm to patients, which officials repeatedly cited as the reason health care fraud ranks among the department's top white-collar priorities. In the Southern District of Florida, the medical director of a cardiovascular testing practice was charged in an $89 million scheme to bill for unnecessary heart tests on student athletes screened on school campuses. According to the charges, the marketing played on fears of sudden cardiac death, and the medical director signed off on results without reviewing them. In one instance, prosecutors allege, he marked as normal a study showing an enlarged heart roughly 11 seconds after opening the images. The student athlete died about 24 days later from complications of an enlarged heart during a basketball practice. The defendant had written that "these kids could be high risk," the charges state, and that "one of them drops dead on the field, they're coming after both of us."

The takedown also included 36 defendants, among them 28 licensed medical professionals, charged in connection with the illegal diversion of opioids and other controlled substances. In one Pennsylvania case, prosecutors allege three defendants ran a voicemail refill line that dispensed Schedule II prescriptions without any patient interaction and kept it running even after some patients who used it overdosed and died.

The action also reflected what the department called unprecedented international cooperation, including the return of several fugitives from overseas and two new additions to the FBI's recently created Most Wanted Fraudsters list.

What it means for independent practices

For independent and small practices, the lesson from both the cases and the experts is less about any single scheme than about being able to see your own billing the way regulators now see it.

Naples said the most practical step is straightforward: "Check your own data and be on top of it and be monitoring it," so a practice can catch problems early and, if necessary, take advantage of voluntary self-disclosure, which the department's policies reward with reduced penalties.

Sumner framed the same point as a matter of posture. Data errors, she warned, are treated as compliance failures and not technical mistakes, and the OIG has signaled that the absence of an effective compliance program is itself an aggravating factor in enforcement, even for the smallest practices.

A workable program does not require a large budget, she said: a designated compliance lead who is not also handling the billing, written policies that match how the practice actually operates, role-specific training and routine auditing of the highest-risk billing areas.

Between them, the two flagged several areas drawing particular scrutiny: telehealth documentation, Medicare Advantage risk adjustment and referral relationships with suppliers such as durable medical equipment companies. A practice does not have to be a target to feel the effects, Naples noted. Even serving as a witness in a supplier's case can mean responding to subpoenas and making staff available for interviews.

Naples also cautioned against reading the takedown as a function of the current administration alone. "This is something that's not going away," he said.

The charges announced Tuesday are allegations, and all defendants are presumed innocent unless proven guilty. Since the Strike Force program began in 2007, the department said, it has charged more than 6,200 defendants who collectively billed federal programs and private insurers more than $45 billion.

For physicians weighing how much to invest in compliance, Sumner offered a simple frame. "Prevention," she said, "really is the best medicine."